Compare DuPont de Nemours Inc (DD) vs ThredUp Inc (TDUP) Price & Performance

DuPont (DD) trades at $144.65, up 2.18% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $232.80. Recent Q2 2026 earnings beat expectations with EPS of $1.88 versus $1.76 expected, driven by healthcare and industrial water demand, leading to a raised full-year 2026 outlook. The company announced strategic wins, including a membrane bioreactor system in Australia and an R&D 100 Award, highlighting innovation strength.

The stock presents growth potential from operational improvements and end-market recovery, but risks include a high P/E ratio of 62.01, net income margin of only 0.79%, and legal settlements over PFAS chemicals. Investor sentiment is positive due to earnings beats and raised guidance, though valuation concerns and liability exposures warrant caution for long-term holders.

ThredUp (TDUP) trades at $3.08, down 4.64% amid a bearish technical signal. The company reported Q2 2026 revenue growth of 16.9% to $90.8 million but missed EPS estimates and cut full-year revenue guidance, triggering a sharp stock decline. Despite a high gross margin of 79.52%, the firm remains unprofitable with a net income margin of -6.65%. Analyst consensus is positive with 57% buy ratings, but recent news highlights shareholder investigations and promotional headwinds.

The outlook is clouded by near-term execution risks and persistent losses, though long-term potential exists if the company can leverage its asset-light model and AI tools to achieve profitability. Key risks include competitive pressures, macroeconomic sensitivity, and the need to improve cost management. Investors should weigh analyst optimism against the company's challenging path to sustained earnings.